Amphista Therapeutics

Several UK firms are now regarded as futurecorns - companies with a value of between $250m and $1bn - which are on a path to unicorn status. Picture: Jon Savage

Move over unicorns, these Scottish firms have been identified as 'futurecorns'
Business